Category

Alibaba

Rectification and revenge: How’s China’s plotting to break up Jack Ma’s Ant Group empire Alibaba

Rectification and revenge: How’s China’s plotting to break up Jack Ma’s Ant Group empire

Jack Ma had accused China's banks of harbouring a "pawnshop mentality". Within days Ant's US$37 billion initial public offering was cancelled by regulators in November Author of the article: Financial Times Ryan McMorrow and Tom Mitchell Publishing date: Dec 31, 2020  •   •  4 minute read Jack Ma has long…
bubmag
December 31, 2020
Asia’s new richest person is a Chinese vaccine investor who made $70 billion in 2020, surpassing Indian billionaire Mukesh Ambani Alibaba

Asia’s new richest person is a Chinese vaccine investor who made $70 billion in 2020, surpassing Indian billionaire Mukesh Ambani

Chinese billionaire Zhong Shanshan made more than $70 billion in 2020 to become the new richest person in Asia, Richard Macauley and Venus Feng reported for Bloomberg. Shanshan's net worth is estimated at $77.8 billion, making him the 11th-richest person in the world right behind Oracle cofounder Larry Ellison.  The 66-year-old…
bubmag
December 31, 2020
Jack Ma’s Bund Finance Summit speech: We’ll keep making mistakes until we make it right Alibaba

Jack Ma’s Bund Finance Summit speech: We’ll keep making mistakes until we make it right

Beijing’s antitrust probe into Alibaba and Ant Group did not just shot down what could have been the world’s largest-ever market debut, it also stirred up a quick barrage of coverage on the whirlwind that still engulfs the largest Chinese internet company by valuation.  However, much of the media coverage,…
bubmag
December 31, 2020
Stocks making the biggest moves premarket: AstraZeneca, Intel, Caterpillar, Alibaba & more Alibaba

Stocks making the biggest moves premarket: AstraZeneca, Intel, Caterpillar, Alibaba & more

Check out the companies making headlines before the bell: AstraZeneca – Britain became the first country to approve the drug maker's Covid-19 vaccine, setting the stage for a rollout of millions of doses. The vaccine is not yet approved in the U.S., with the FDA still to review large-scale trials. The…
bubmag
December 30, 2020
Alibaba’s $10b buyback plan fails to halt stock slide as regulatory concerns mount Alibaba

Alibaba’s $10b buyback plan fails to halt stock slide as regulatory concerns mount

Alibaba shares slumped 9% to their lowest since June on Monday, as the firm’s upsized $10 billion buyback programme failed to ease concerns about a regulatory crackdown on co-founder Jack Ma’s e-commerce and financial empire. A sharp sell-off over two sessions has knocked almost $116 billion off the tech giant’s Hong…
bubmag
December 28, 2020
Chinese online tutor Zuoyebang raises over $1.6b from Alibaba, SoftBank, others Alibaba

Chinese online tutor Zuoyebang raises over $1.6b from Alibaba, SoftBank, others

Photo: Internet Archive Chinese online tutor Zuoyebang has raised more than $1.6 billion in a new funding round from investors including Alibaba Group and SoftBank’s Vision Fund, the company said on Monday. Existing investors Tiger Global, Sequoia Capital China and FountainVest Partners have also participated, Zuoyebang said in a news statement, without disclosing its…
bubmag
December 28, 2020